Literature DB >> 17437344

Anaplastic thyroid carcinoma with long term survival after combined treatment: case report.

Osman Kurukahvecioglu1, Bahadir Ege, Aylar Poyraz, Ekmel Tezel, Ferit Taneri.   

Abstract

Anaplastic thyroid carcinoma (ATC) is associated with an almost uniformly rapid and lethal clinical course. ATC grows rapidly and invades surrounding tissues at an early stage. Despite surgery, chemotherapy and radiotherapy, few patients with ATC live more than 1 year follow-up diagnosis. The mean survival is reported to be only 7.2 months. Treatment of ATC is still controversial because of its rarity and advanced stage at the time of diagnosis. We report herein an unusual case of ATC, 35 year old woman. She is alive without evidence of recurrence more than 36 months after combined therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437344

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  6 in total

1.  Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.

Authors:  Xiaoguang Shi; Rengyun Liu; Shen Qu; Guangwu Zhu; Justin Bishop; Xiaoli Liu; Hui Sun; Zhongyan Shan; Enhua Wang; Yahong Luo; Xianghong Yang; Jiajun Zhao; Jianling Du; Adel K El-Naggar; Weiping Teng; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2015-01-13       Impact factor: 5.958

2.  Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy.

Authors:  Marshall Tulloch-Reid; Monica C Skarulis; Steven I Sherman; Nicholas J Sarlis; Libero Santarpia
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

Review 3.  Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.

Authors:  Ichiro Abe; Alfred King-Yin Lam
Journal:  Curr Oncol Rep       Date:  2021-02-13       Impact factor: 5.075

4.  A large nonmetastatic anaplastic thyroid cancer with complete thyroidal confinement.

Authors:  Jeffrey C Xing; Justin A Bishop; Nestoras Mathioudakis; Nishant Agrawal; Ralph P Tufano
Journal:  Case Rep Med       Date:  2011-09-07

5.  Expression of Pax8 is decreased and bortezomib does not increase the iodine uptake in thyroid carcinoma cells.

Authors:  Huan-Jun Wang; Jin-Ming Yao; Zhong-Wen Zhang; Jun-Yu Zhao; Hong-Xia Shang; Lin Liao; Jian-Jun Dong
Journal:  Thorac Cancer       Date:  2015-07-14       Impact factor: 3.500

Review 6.  Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the Literature.

Authors:  Aurora Mirabile; Matteo Biafora; Leone Giordano; Gianluigi Arrigoni; Maria Giulia Cangi; Italo Dell'Oca; Francesca Lira Luce; Davide Di Santo; Andrea Galli; Michele Tulli; Renata Mellone; Davide Valsecchi; Vanesa Gregorc; Mario Bussi
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.